FDA finds scant evidence that a generic drug helps autism
TL;DR
The FDA’s review concludes there is scant evidence that a generic drug provides meaningful benefit for autism, raising doubts about its efficacy and underscoring the need for more rigorous research.
- FDA finds little evidence that a drug touted by Trump can help people with autism AP News
- FDA approves leucovorin for rare genetic condition, but not for autism CNN
- FDA approves new use of synthetic vitamin B9 — but not for autism symptoms NBC News
- FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients Politico
- FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism The Hill
Want the full story? Read the original reporting
Read on AP News